Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Essential news and practice changing trials in oesophageal, gastroesophageal junction and gastric cancer in 2021

Essential news and practice changing trials in oesophageal, gastroesophageal junction and gastric... Summary In this short review we aim to summarize the highlights in gastric, gastroesophageal junction and oesophageal cancer in 2021. We will discuss practice changing studies and potential guideline changes based on these trials, with focus on the latest developments regarding checkpoint inhibitors. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Essential news and practice changing trials in oesophageal, gastroesophageal junction and gastric cancer in 2021

Loading next page...
 
/lp/springer-journals/essential-news-and-practice-changing-trials-in-oesophageal-xF3slkHTCh
Publisher
Springer Journals
Copyright
2022 The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-022-00809-6
Publisher site
See Article on Publisher Site

Abstract

Summary In this short review we aim to summarize the highlights in gastric, gastroesophageal junction and oesophageal cancer in 2021. We will discuss practice changing studies and potential guideline changes based on these trials, with focus on the latest developments regarding checkpoint inhibitors.

Journal

memo - Magazine of European Medical OncologySpringer Journals

Published: May 9, 2022

Keywords: oncology; medicine/public health, general

References